Allianz Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-32,085
| Closed | -$485K | – | 1699 |
|
|
2022
Q2 | $485K | Buy |
32,085
+3,350
| +12% | +$50.6K | ﹤0.01% | 1669 |
|
|
2022
Q1 | $341K | Sell |
28,735
-1,019
| -3% | -$12.1K | ﹤0.01% | 1779 |
|
|
2021
Q4 | $482K | Sell |
29,754
-7,600
| -20% | -$123K | ﹤0.01% | 1835 |
|
|
2021
Q3 | $1.07M | Buy |
37,354
+83
| +0.2% | +$2.37K | ﹤0.01% | 1550 |
|
|
2021
Q2 | $1.26M | Buy |
37,271
+11
| +0% | +$372 | ﹤0.01% | 1421 |
|
|
2021
Q1 | $1.13M | Sell |
37,260
-179
| -0.5% | -$5.41K | ﹤0.01% | 1425 |
|
|
2020
Q4 | $1.85M | Sell |
37,439
-18,942
| -34% | -$938K | ﹤0.01% | 1320 |
|
|
2020
Q3 | $2.16M | Sell |
56,381
-1,511
| -3% | -$58K | ﹤0.01% | 1228 |
|
|
2020
Q2 | $2.5M | Sell |
57,892
-3,936
| -6% | -$170K | ﹤0.01% | 1208 |
|
|
2020
Q1 | $1.61M | Buy |
+61,828
| New | +$1.61M | ﹤0.01% | 1303 |
|